Stay updated on Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s displayed software/webpage revision version was updated from v3.5.2 to v3.5.3 without changing any underlying study details.
    Difference
    0.0%
    Check dated 2026-04-24T05:54:24.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:21:10.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T21:07:56.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T20:10:13.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    A minor site revision tag (Revision: v3.4.2) was added, and the previous government funding notice about updates and operations was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T02:39:51.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and NIH operations was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-03T23:48:32.000Z thumbnail image

Stay in the know with updates to Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib + Dostarlimab in Platinum Resistant Ovarian Cancer Clinical Trial page.